Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides

References

• Agrawal AK, Harde H, Thanki K, Jain S. (2014). Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. Biomacromolecules 15:1–11.
   PubMed Web of Science ®Google Scholar
• Aparicio-Blanco J, Sebastian V, Rodriguez-Amaro M, et al. (2019). Size-tailored design of highly monodisperse lipid nanocapsules for drug delivery. J Biomed Nanotechnol 15:1149–61.
   PubMed Web of Science ®Google Scholar
• Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM. (2007). Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 86:159–66.
   PubMed Web of Science ®Google Scholar
• Drucker DJ. (2020). Advances in oral peptide therapeutics. Nat Rev Drug Discov 19:277–89.
   PubMed Web of Science ®Google Scholar
• Fosgerau K, Hoffmann T. (2015). Peptide therapeutics: current status and future directions. Drug Discov Today 20:122–8.
   PubMed Web of Science ®Google Scholar
• Granja A, Neves AR, Sousa CT, et al. (2019). EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers. Heliyon 5:e02020.
   PubMed Web of Science ®Google Scholar
• Groo AC, Saulnier P, Gimel JC, et al. (2013). Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomedicine 8:4291–302.
   PubMed Web of Science ®Google Scholar
• Guo S, Liang Y, Liu L, et al. (2021). Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnology 19:32.
   PubMed Web of Science ®Google Scholar
• Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. (2022). Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 182:114097.
   PubMed Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P, Benoit JP. (2009). Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379:201–9.
   PubMed Web of Science ®Google Scholar
• Jain D, Mahammad SS, Singh PP, Kodipyaka R. (2019). A review on parenteral delivery of peptides and proteins. Drug Dev Ind Pharm 45:1403–20.
   PubMed Web of Science ®Google Scholar
• Jain KK. (2020). An overview of drug delivery systems. Methods Mol Biol 2059:1–54.
   PubMedGoogle Scholar
• Jain S, Rathi VV, Jain AK, et al. (2012). Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine (Lond) 7:1311–37.
   PubMed Web of Science ®Google Scholar
• Labrak Y, Heurtault B, Frisch B, et al. (2022). Impact of anti-PDGFRalpha antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells. Int J Pharm 618:121623.
   PubMedGoogle Scholar
• Laine AL, Gravier J, Henry M, et al. (2014). Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring. J Control Release 188:1–8.
   PubMed Web of Science ®Google Scholar
• Lau JL, Dunn MK. (2018). Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26:2700–7.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Yu M, et al. (2022). The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery. Acta Pharm Sin B 12:1460–72.
   PubMed Web of Science ®Google Scholar
• Liang Y, Ding R, Wang H, et al. (2022). Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption. Drug Deliv 29:305–15.
   PubMed Web of Science ®Google Scholar
• Mittal G, Carswell H, Brett R, et al. (2011). Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer’s pathology. J Control Release 150:220–8.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S. (2015). Lipid based nanocapsules: a multitude of biomedical applications. Curr Pharm Biotechnol 16:322–32.
   PubMed Web of Science ®Google Scholar
• Nauck MA, Quast DR, Wefers J, Meier JJ. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism 46:101102.
   PubMed Web of Science ®Google Scholar
• Perrier T, Saulnier P, Fouchet F, et al. (2010). Post-insertion into Lipid NanoCapsules (LNCs): from experimental aspects to mechanisms. Int J Pharm 396:204–9.
   PubMed Web of Science ®Google Scholar
• Radwan SAA, El-Maadawy WH, ElMeshad AN, et al. (2020). Impact of reverse micelle loaded lipid nanocapsules on the delivery of gallic acid into activated hepatic stellate cells: a promising therapeutic approach for hepatic fibrosis. Pharm Res 37:180.
   PubMed Web of Science ®Google Scholar
• Roger E, Gimel JC, Bensley C, et al. (2017). Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model. J Control Release 253:11–8.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Garcion E, Benoit JP. (2009). Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release 140:174–81.
   PubMed Web of Science ®Google Scholar
• Sheng J, He H, Han L, et al. (2016). Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. J Control Release 233:181–90.
   PubMed Web of Science ®Google Scholar
• Song Y, Shi Y, Zhang L, et al. (2019). Synthesis of CSK-DEX-PLGA nanoparticles for the oral delivery of exenatide to improve its mucus penetration and intestinal absorption. Mol Pharm 16:518–32.
   PubMed Web of Science ®Google Scholar
• Topin-Ruiz S, Mellinger A, Lepeltier E, et al. (2021). p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8(+) T lymphocytes. Int J Pharm 593:120111.
   PubMedGoogle Scholar
• Tsakiris N, Papavasileiou M, Bozzato E, et al. (2019). Combinational drug-loaded lipid nanocapsules for the treatment of cancer. Int J Pharm 569:118588.
   PubMedGoogle Scholar
• Valdes-Ramos R, Guadarrama-Lopez AL, Martinez-Carrillo BE, Benitez-Arciniega AD. (2015). Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 15:54–63.
   PubMed Web of Science ®Google Scholar
• Xu Y, De Keersmaecker H, Braeckmans K, et al. (2020a). Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment. Biomaterials 255:120209.
   PubMed Web of Science ®Google Scholar
• Xu Y, Van Hul M, Suriano F, et al. (2020b). Novel strategy for oral peptide delivery in incretin-based diabetes treatment. Gut 69:911–9.
   PubMed Web of Science ®Google Scholar
• Zaman R, Islam RA, Ibnat N, et al. (2019). Current strategies in extending half-lives of therapeutic proteins. J Control Release 301:176–89.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu J, Shan W, et al. (2016). Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins. Angew Chem Int Ed Engl 55:3309–12.
   PubMed Web of Science ®Google Scholar